Document is current
Any future updates will be listed below
-
Authors
Weiss, Pamela F. https://orcid.org/0000-0002-9724-0443
Sears, Cora E.
Brandon, Timothy G.
Forrest, Christopher B.
Neu, Emily
Kohlheim, Melanie
Leal, Jenny
Xiao, Rui
Lovell, Daniel
-
Funding
Funding for this research was provided by:
Patient-Centered Outcomes Research Institute (CER-2020C1-19212)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR079822-01)
Spondylitis Association of America
- License Information
-
More Information
Article History
Received: 4 April 2022
Accepted: 17 December 2022
First Online: 8 February 2023
Declarations
:
: This study’s protocol was reviewed and approved by the Children’s Hospital of Philadelphia’s (IRB 21-018442) Committees of the Protection of Human Subjects on 6/1/2021. Written informed consent to participate will be obtained from all participants.
: Not applicable
: Drs. Weiss and Lovell consult for pharmaceutical companies but this consulting work is not related to the PCORI-funded project.Dr. Weiss: Lily, Biogen, Pfizer, Inc., and NovartisDr. Lovel: United BioSource Corporation, Hoffman-LaRoche, Inc., Janssen Research & Development, LLC, Bristol -Myers Squibb, AstraZeneca, Pfizer, Inc., AbbVie Inc., GlaxoSmithKline, Novartis Pharmaceuticals, Abbott Laboratories, and Roche Laboratories, Inc.
